InDel polymorphisms in quantitative posttransplant chi merism evaluation

Reduction of minimal residual disease to undetectable levels is the key criterion for efficiency of allogeneic hematopoietic stem cell transplantation (alloHSCT), along with engraftment of transplanted cells with complete replacement of recipient hematopoiesis, i. e., full posttransplant chimerism. Among different approaches, molecular genetic techniques are preferable, being based on the analysis of highly polymorphic DNA sequences (short tandem repeats, STRs). However, this approach, despite its high specificity, has a limited sensitivity. In this regard, it seems appropriate to introduce more sensitive diagnostic solutions, in particular, analysis of insertion/deletion (InDel) polymorphisms, followed by real-time detection of PCR products. The data obtained upon analysis of several genetic markers have shown higher sensitivity of this method. However, the deviations in the range of 10 to 90 % in evaluation of the cell ratios indicates the feasibility of using this approach just to evaluate the residual populations of recipient cells.

1. Alizadeh M., Bernard M., Danic B. et al. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction // Blood. – 2002. – Vol. 99. – № 12. – P. 4618–4625.

2. Allor C., Einum D. D., Scarpetta M. Identification and characterization of variant alleles at CODIS STR loci// J. Forensic Sci. – 2005. – Vol. 50. – № 5. – P. 1128–1133.

3. Alpar D., Nagy G., Hohoff C. et al. Sex chromosome changes after sex-mismatched allogeneic bone marrow transplantation can mislead the chimerism analysis // Pediatr. Blood Cancer. – 2010. – Vol. 55. – № 6. – P. 1239–1242.

4. Bolan C. D., Leitman S. F., Griffith L. M. et al. Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation // Blood. – 2001. – Vol. 98 – № 6. – P. 1687–1694.

5. Choe W., Hwang M. A., Jang S. et al.Establishing a populationbased HLA-antibody panel for flow cytometric monitoring of chimerism in HLAhaploidentical stem cell transplantation // Ann. Clin. Lab. Sci. – 2016. – Vol. 46. – № 2. - P. 161–167.

6. Ensenberger M. G., Hill C. R., McLaren R. S. et al. Developmental validation of the PowerPlex?? 21 System // Forensic Sci. Int. Genet. – 2014. – Vol. 9. – № 1. – P. 169–178.

7. Fehse B., Chukhlovin A., Kuhlcke K. et al. Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation// J. Hematother. Stem Cell Res. – 2001. – Vol. 10. – № 3. – P. 419–425.

8. Krenke B. E., Tereba A., Anderson S. J. et al. Validation of a 16locus fluorescent multiplex system// J. Forensic Sci. – 2002. – Vol. 47. – № 4. – P. 773–785.

9. Kristt D. Assessing quantitative chimerism longitudinally: technical considerations, clinical applications and routine feasibility/ D. Kristt, J. Stein, I. Yaniv, T. Klein // Bone Marrow Transplant. – 2007. – Vol. 39. – № 5. – P. 255–268.

10. Lion T., Watzinger F., Preuner S. et al. The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation // Leukemia. – 2012. – Vol. 26. – № 8. – P. 1821–1828.

11. Nollet F.Standardisation of multiplex fluorescent short tandem repeat analysis for chimerism testing. / F. Nollet, J. Billiet, D. Selleslag, A. Criel // Bone Marrow Transplant. – 2001. – Vol. 28. – № 5. – P. 511–518.

12. Schumm M., Feuchtinger T., Pfeiffer M. Flow cytometry with anti HLAantibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation// Bone Marrow Transplant. – 2007. – Vol. 39. – № 12. – P. 767–773.